BDD-10103

N/A

Report date: 2023/02/04 20:39:20

Base Information

Drug NameBDD-10103
Drug Alias NameBDD-10103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersVoltage-gated calcium channel blockers
TargetsSodium channel alpha subunitVoltage-gated calcium channel
Therapy Area/IndicationsBack PainMuscle Spasticity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBirds Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBirds PharmaAd4-Pharma
Active IndicationsN/A
Inactive IndicationsBack PainMuscle Spasticity

Other Information

ATC CodeN/A
Related LinksN/A